Goldman Sachs’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $48.7M | Buy |
|
|||||
|
2019
Q4 | $30.4M | Buy |
|
|||||
|
2019
Q3 | $13.3M | Buy |
|
|||||
|
2019
Q2 | $6.47M | Sell |
|
|||||
|
2019
Q1 | $4.96M | Buy |
|
|||||
|
2018
Q4 | $3.63M | Buy |
|
|||||
|
2018
Q3 | $1.67M | Sell |
|
|||||
|
2018
Q2 | $1.33M | Buy |
|
|||||
|
2018
Q1 | $393K | Buy |
|
|||||
|
2017
Q4 | $246K | Buy |
|
|||||
|
2017
Q3 | $240K | Sell |
|
|||||
|
2017
Q2 | $1.37M | Buy |
|
|||||
|
2017
Q1 | $1.46M | Buy |
|